| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0895-4356(98)00159-0 |
| P8608 | Fatcat ID | release_x7yykiwcubaddjgul6cp2ay2oi |
| P698 | PubMed publication ID | 10235168 |
| P50 | author | John Ioannidis | Q6251482 |
| P2093 | author name string | Contopoulos-Ioannidis DG | |
| Lau J | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability | Q28268075 | ||
| Quantitative Synthesis in Systematic Reviews | Q29614894 | ||
| Clinical Efficacy of High-Dose Acyclovir in Patients with Human Immunodeficiency Virus Infection: A Meta-Analysis of Randomized Individual Patient Data | Q32041499 | ||
| Meta-analysis of the literature or of individual patient data: is there a difference? | Q34334544 | ||
| The existence of publication bias and risk factors for its occurrence | Q34373168 | ||
| Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials | Q34436046 | ||
| Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group | Q36790212 | ||
| Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies | Q36860588 | ||
| Meta-analysis: Unresolved issues and future developments | Q37150101 | ||
| The impact of stopping rules on heterogeneity of results in overviews of clinical trials | Q39085773 | ||
| Epstein-Barr virus infection of HIV-seropositive individuals is transiently suppressed by high-dose acyclovir treatment. | Q39195449 | ||
| Practical problems in interim analyses, with particular regard to estimation | Q39361217 | ||
| Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction | Q40374325 | ||
| Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. | Q40590984 | ||
| Large trials vs meta-analysis of smaller trials: how do their results compare? | Q40923138 | ||
| Cumulative meta-analysis of therapeutic trials for myocardial infarction | Q41112231 | ||
| Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials | Q41187186 | ||
| Effective and acceptable treatment for depression. | Q43153916 | ||
| The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care | Q43418492 | ||
| Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis | Q43471039 | ||
| Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection | Q45766048 | ||
| A pilot study of low-dose zidovudine in human immunodeficiency virus infection | Q45853487 | ||
| Meta-analysis: is moving the goal post the answer? | Q48029762 | ||
| Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness | Q49255435 | ||
| The population risk as an explanatory variable in research synthesis of clinical trials | Q52298897 | ||
| Stopping rules and estimation problems in clinical trials | Q52547926 | ||
| Meta-analyses of randomised controlled trials | Q52898066 | ||
| Predictors and Impact of Patients Lost to Follow-Up in a Long-Term Randomized Trial of Immediate Versus Deferred Antiretroviral Treatment | Q52899023 | ||
| Summing up evidence: one answer is not always enough | Q52900179 | ||
| Issues in Comparisons Between Meta-analyses and Large Trials | Q52901853 | ||
| Predictive ability of meta-analyses of randomised controlled trials | Q58467929 | ||
| The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group | Q67832359 | ||
| Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects | Q68090312 | ||
| Uncertainty of the time of first significance in random effects cumulative meta-analysis | Q71810911 | ||
| Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group | Q72129375 | ||
| The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group | Q72215145 | ||
| The impact of high-risk patients on the results of clinical trials | Q73877878 | ||
| Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials | Q74121809 | ||
| An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials | Q77429377 | ||
| P433 | issue | 4 | |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 281-291 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Journal of Clinical Epidemiology | Q6294959 |
| P1476 | title | Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data | |
| P478 | volume | 52 |
| Q24288705 | A comparison of statistical methods for identifying out-of-date systematic reviews |
| Q33260932 | A system for rating the stability and strength of medical evidence |
| Q46922376 | Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis. |
| Q89579269 | Charting the landscape of graphical displays for meta-analysis and systematic reviews: a comprehensive review, taxonomy, and feature analysis |
| Q51644667 | Cumulative Metaanalysis of High-frequency Versus Conventional Ventilation in Premature Neonates |
| Q47869388 | Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: A comparison of new and existing tests |
| Q33437253 | Evidence synthesis as the key to more coherent and efficient research |
| Q24289247 | Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses |
| Q52885903 | GRADE guidelines: 5. Rating the quality of evidence: publication bias |
| Q24804098 | Identifying null meta-analyses that are ripe for updating |
| Q31126782 | Individual participant data meta-analyses compared with meta-analyses based on aggregate data |
| Q36103365 | Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002. |
| Q30587472 | Integrative Data Analysis in Clinical Psychology Research |
| Q37329334 | Interpretation of tests of heterogeneity and bias in meta-analysis |
| Q44304796 | Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions |
| Q24240811 | Long-term opioid management for chronic noncancer pain |
| Q24244481 | Long-term opioid management for chronic noncancer pain |
| Q34009241 | Meta-analysis in hematology and oncology |
| Q37620160 | Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse |
| Q56944438 | Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions |
| Q43959142 | Molecular bias |
| Q48507006 | Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications |
| Q30635282 | Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data |
| Q33504261 | Prospective meta-analysis using individual patient data in intensive care medicine |
| Q64094283 | Quo Vadis, Cochrane Collaboration? |
| Q29615456 | Replication validity of genetic association studies |
| Q45797850 | Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis |
| Q42612025 | State of the evidence: current status and prospects of meta-analysis in infectious diseases |
| Q42240550 | The evolution of laparoscopy in abdominal surgery: a meta-analysis of the effect on infectious outcomes |
| Q24801807 | The strengths and limitations of meta-analyses based on aggregate data |
| Q24289436 | Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis |
| Q35297749 | Ventilation strategies and outcome in randomised trials of high frequency ventilation |
| Q24243317 | When and how to update systematic reviews |
| Q24246171 | When and how to update systematic reviews |
Search more.